Numerous studies have now shown that around 95% of people with hepatitis C genotypes 1, 2 and 4 can be cured if they receive a combination of at least two direct-acting antivirals. These cure rates include people with cirrhosis. Studies have shown that at least 90% of people with hepatitis C genotype 3 can be cured with a two-drug combination.